STUDIO

Sara Mangsbo Ultimovacs

An in-depth look at Ultimovacs’ cancer vaccine

The field of immuno-oncology is growing, and cancer vaccines are a big part of that. Norwegian biotech Ultimovacs is developing its own cancer vaccine technology platform....

RECOMMENDED READING

Sensidose

Rising sales for newly listed Sensidose

Sensidose, active in Parkinson’s disease, reports its best sales figures to date in the...
Promore Pharmas Q1 studieavancemang

Promore Pharma’s Q1 characterised by study progress

The reporting season is in full swing and Promore Pharma has now joined the...

EVENT